GO:1904045 cellular response to aldosterone: Signaling Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1904045 (cellular response to aldosterone) describes any process by which a cell changes its state or activity in response to aldosterone, including movement, secretion, enzyme production and gene expression.
• Aldosterone is the principal mineralocorticoid hormone of the renin-angiotensin-aldosterone system (RAAS) and acts on cells such as renal tubular cells, vascular endothelial cells, cardiac fibroblasts and neurons [1,4].
• The classical cellular response involves binding to the mineralocorticoid receptor (NR3C2), nuclear translocation, and transcriptional regulation of target genes controlling sodium and potassium transport [1,3].
• Rapid, non-genomic aldosterone signaling also occurs in the cytoplasm and at the membrane, modulating kinases and ion channels within minutes [4,8].
• Dysregulated cellular responses to aldosterone underlie primary aldosteronism, hypertension, cardiac fibrosis and vascular endothelial damage [1,3,8].
• Aldosterone-producing adenomas with KCNJ5 mutations show distinct cellular ecosystems and aldosterone production profiles that can be dissected with multiomics and CRISPR models [2,6].
Description
GO:1904045, cellular response to aldosterone, is a Gene Ontology biological process term that captures any change in a cell's state or activity resulting from an aldosterone stimulus. Aldosterone is a steroid hormone produced in the adrenal cortex and is the final effector of the renin-angiotensin-aldosterone system (RAAS), which regulates blood pressure, electrolyte balance and extracellular volume. At the cellular level, aldosterone acts on diverse cell types, including renal tubular epithelial cells, vascular endothelial cells, cardiac fibroblasts and specific neuronal populations, to modulate ion transport, gene expression, oxidative stress and secretory activity [1,4,7]. Understanding this process is central to hypertension research, cardiovascular medicine and adrenal tumor biology. Primary aldosteronism, the most common secondary cause of hypertension, is driven by excessive aldosterone production and inappropriate cellular responses in target tissues. Aldosterone also exerts damaging effects on the vascular endothelium and the heart, contributing to fibrosis, inflammation and remodeling [4,8]. Recent multiomics studies of aldosterone-producing adenomas have revealed clinically relevant cellular ecosystems and mutation-specific features, such as KCNJ5 mutations, that shape aldosterone output. For researchers, GO:1904045 provides a structured framework to annotate genes and pathways involved in aldosterone sensing and response. It connects molecular events, such as mineralocorticoid receptor activation and transcriptional reprogramming, to physiological outcomes and disease phenotypes [1,3,6]. This article reviews the definition, mechanism, key genes, disease links and experimental methods used to study cellular response to aldosterone.
cellular response to aldosterone At A Glance
| GO ID | GO:1904045 |
|---|---|
| GO term | cellular response to aldosterone |
| Ontology | biological_process |
| Synonym | none |
| Definition | Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aldosterone stimulus. |
| Major function | Mediates cellular adaptation to aldosterone, including ion transport, gene expression and secretory changes [1,3]. |
| Key receptor | Mineralocorticoid receptor (NR3C2) is the primary mediator of genomic aldosterone responses [1,3]. |
| Associated system | Renin-angiotensin-aldosterone system (RAAS). |
| Disease relevance | Primary aldosteronism, hypertension, cardiac fibrosis, vascular endothelial dysfunction [1,3,4,8]. |
What Is GO:1904045?
In our own words, GO:1904045 (cellular response to aldosterone) refers to any process that results in a change in the state or activity of a single cell in response to an aldosterone stimulus. This includes changes in cell movement, secretion, enzyme production, gene expression and other activities. The term is a biological process and is used to annotate gene products that participate in sensing aldosterone and executing downstream cellular changes.
Why Is cellular response to aldosterone Important in Cell Biology?
Cellular response to aldosterone is important because it links a hormonal signal to fundamental cell behaviors that control blood pressure, electrolyte homeostasis and cardiovascular health. Excessive or inappropriate aldosterone signaling is a major driver of hypertension, cardiac fibrosis and endothelial injury, making this process a prime target for drug discovery and biomarker development [1,3,4,8]. In addition, aldosterone-producing adenomas provide a human disease model in which cellular responses to aldosterone are constitutively activated, offering opportunities to study tumor biology and precision medicine [2,6].
• Regulates sodium reabsorption and potassium secretion in renal tubular cells, controlling blood pressure and fluid balance [1,3].
• Mediates rapid non-genomic effects on vascular tone and ion channels within minutes [4,8].
• Drives cardiac fibroblast activation and myocardial fibrosis in heart failure and hypertension.
• Contributes to endothelial dysfunction and vascular inflammation.
• Is central to the pathophysiology of primary aldosteronism, a common cause of secondary hypertension.
• Influences salt appetite through HSD2 neurons in the brain.
• Is dysregulated in aldosterone-producing adenomas, including those with KCNJ5 mutations.
• Provides a mechanistic basis for mineralocorticoid receptor antagonist therapy [1,3].
• Serves as a model for studying steroid hormone signaling and transcriptional regulation [1,6].
• Offers targets for CRISPR-based functional genomics in adrenal and cardiovascular cells [2,6].
What Happens During cellular response to aldosterone?
Aldosterone sensing and receptor binding
In simple terms: The cell first detects aldosterone when the hormone binds to its receptor.
Aldosterone, a mineralocorticoid hormone produced by the adrenal cortex, diffuses across the plasma membrane and binds to the mineralocorticoid receptor (NR3C2) in target cells [1,3]. This binding is the initiating event of the cellular response and occurs in renal tubular cells, vascular endothelial cells, cardiac fibroblasts and specific neurons [1,4,7]. The receptor is a ligand-activated transcription factor that, upon hormone binding, undergoes a conformational change that releases heat shock proteins and exposes nuclear localization signals.
Genomic transcriptional regulation
In simple terms: The activated receptor moves to the nucleus and switches genes on or off.
After aldosterone binding, the mineralocorticoid receptor translocates to the nucleus, dimerizes and binds to hormone response elements in DNA, recruiting coactivators or corepressors to modulate transcription of target genes [1,3]. This genomic response typically takes hours and leads to changes in expression of genes controlling ion transport, such as SGK1, ENaC subunits and Na+/K+-ATPase, as well as genes involved in oxidative stress and inflammation [1,6]. In aldosterone-producing adenomas, transcriptional programs are rewired, and EGR1 has been shown to regulate oxidative stress and aldosterone production in adrenal cells.
Non-genomic rapid signaling
In simple terms: Aldosterone can also trigger fast cellular changes without altering gene expression.
In addition to genomic effects, aldosterone elicits rapid non-genomic responses within minutes, likely mediated by membrane-associated mineralocorticoid receptors or other membrane proteins [4,8]. These rapid effects include activation of protein kinases, changes in intracellular calcium and modulation of ion channel activity, which can alter vascular tone and endothelial function [4,8]. Such non-genomic signaling contributes to the acute regulation of salt and water balance and to vascular reactivity.
Cellular and physiological outputs
In simple terms: The cell changes its behavior, such as transporting more salt or secreting factors.
The integrated cellular response to aldosterone includes increased sodium reabsorption and potassium secretion in renal epithelial cells, altered endothelial permeability and adhesion molecule expression, and activation of cardiac fibroblasts [1,4,8]. In the brain, aldosterone acts on HSD2 neurons to drive salt appetite, a behavioral response that complements renal sodium conservation. These outputs are essential for volume homeostasis but become maladaptive in disease states such as primary aldosteronism and heart failure [1,3,8].
Feedback and crosstalk with other pathways
In simple terms: The response is tuned by other signals and feedback loops.
Cellular response to aldosterone is modulated by crosstalk with angiotensin II, glucocorticoids and inflammatory cytokines, and by feedback within the RAAS [1,5]. In glucocorticoid-remediable aldosteronism, ectopic expression of aldosterone synthase under ACTH control leads to excessive aldosterone production and altered cellular responses. Multiomics analyses of aldosterone-producing adenomas have revealed distinct cellular ecosystems and mutation-specific signaling that influence aldosterone output and clinical outcomes.
Key Genes Involved in GO:1904045 cellular response to aldosterone
The following genes and proteins are central to cellular response to aldosterone, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NR3C2 | Mineralocorticoid receptor; binds aldosterone and regulates transcription | Primary mediator of genomic aldosterone responses; target for KO and point mutation studies [1,3] |
| SGK1 | Serum/glucocorticoid-regulated kinase; downstream effector of MR | Regulates ion transport; often used as readout of aldosterone activity |
| SCNN1A | Epithelial sodium channel alpha subunit; mediates sodium reabsorption | Functional target of aldosterone; knockout models show salt-wasting |
| SCNN1B | Epithelial sodium channel beta subunit | Component of ENaC; studied in aldosterone-responsive tissues |
| SCNN1G | Epithelial sodium channel gamma subunit | Component of ENaC; mutations cause Liddle syndrome |
| ATP1A1 | Na+/K+-ATPase alpha subunit; drives sodium-potassium exchange | Aldosterone-regulated; mutations in aldosterone-producing adenomas |
| ATP2B3 | Plasma membrane calcium ATPase; calcium homeostasis | Mutated in aldosterone-producing adenomas |
| KCNJ5 | Potassium channel; regulates adrenal cell membrane potential | Mutations cause aldosterone-producing adenomas; key research target |
| CYP11B2 | Aldosterone synthase; catalyzes final steps of aldosterone synthesis | Rate-limiting enzyme for aldosterone production; target for KO and knock-in |
| CYP11B1 | 11-beta-hydroxylase; cortisol synthesis | Chimeric gene with CYP11B2 causes glucocorticoid-remediable aldosteronism |
| EGR1 | Early growth response transcription factor | Regulates oxidative stress and aldosterone production in adrenal cells |
| HSD11B2 | 11-beta-hydroxysteroid dehydrogenase type 2; inactivates cortisol | Protects MR from glucocorticoids; important in aldosterone target tissues |
| POMC | Pro-opiomelanocortin; precursor to ACTH | ACTH regulates aldosterone in GRA; relevant to adrenal biology |
| AGTR1 | Angiotensin II receptor type 1 | Upstream regulator of aldosterone production; crosstalk with MR signaling |
| REN | Renin; rate-limiting enzyme of RAAS | Controls aldosterone production; knockout models alter aldosterone levels |
| ACE | Angiotensin-converting enzyme; generates angiotensin II | Regulates aldosterone secretion; target for pharmacological studies |
| NPPA | Atrial natriuretic peptide; counter-regulates RAAS | Modulates aldosterone effects; used in cardiovascular research |
| NPPB | B-type natriuretic peptide; cardiac stress marker | Reflects cardiac response to aldosterone and volume overload |
How Is cellular response to aldosterone Regulated?
Cellular response to aldosterone is regulated at multiple levels. The availability of aldosterone is controlled by the RAAS, with renin release from juxtaglomerular cells as the rate-limiting step, and by ACTH in conditions such as glucocorticoid-remediable aldosteronism [1,5]. At the cellular level, the mineralocorticoid receptor is regulated by heat shock proteins, phosphorylation and cofactor recruitment, and its activity is modulated by crosstalk with angiotensin II and glucocorticoid signaling [1,3]. 11-beta-hydroxysteroid dehydrogenase type 2 (HSD11B2) locally inactivates cortisol to prevent inappropriate MR activation by glucocorticoids. In aldosterone-producing adenomas, somatic mutations in KCNJ5, ATP1A1, ATP2B3 and other genes alter membrane potential and calcium signaling, leading to constitutive aldosterone production and altered cellular responses. EGR1 has been identified as a regulator of oxidative stress and aldosterone production in adrenal cells, adding another layer of transcriptional control.
cellular response to aldosterone and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| KCNJ5 | Aldosterone-producing adenoma; primary aldosteronism | Knock-in of KCNJ5 mutation in adrenal cell lines; KO to study channel function |
| NR3C2 | Hypertension; mineralocorticoid resistance | KO and point mutation in renal or vascular cells to dissect MR signaling [1,3] |
| CYP11B2 | Primary aldosteronism; glucocorticoid-remediable aldosteronism | Knock-in of chimeric CYP11B1/CYP11B2; overexpression in adrenal cells |
| EGR1 | Adrenal oxidative stress; aldosterone production | KO and overexpression in adrenal cells to study regulation of aldosterone |
| HSD11B2 | Hypertension; apparent mineralocorticoid excess | KO in renal cells to model impaired cortisol inactivation |
Primary aldosteronism and hypertension
Primary aldosteronism is characterized by excessive aldosterone production and inappropriate cellular responses in target tissues, leading to hypertension, hypokalemia and cardiovascular damage. The cellular response to aldosterone in renal tubular cells drives sodium retention and potassium excretion, contributing to volume expansion and hypertension. Multiomics studies of aldosterone-producing adenomas have revealed distinct cellular ecosystems and mutation-specific features, such as KCNJ5 mutations, that correlate with clinical outcomes.
Cardiac fibrosis and heart failure
Aldosterone promotes cardiac fibroblast proliferation and extracellular matrix deposition, leading to myocardial fibrosis and diastolic dysfunction. These cellular responses are mediated by mineralocorticoid receptor activation and are exacerbated by oxidative stress and inflammation. Mineralocorticoid receptor antagonists are used clinically to block these deleterious effects [1,8].
Vascular endothelial dysfunction
Aldosterone damages the vascular endothelium by increasing oxidative stress, reducing nitric oxide bioavailability and promoting adhesion molecule expression. These cellular responses contribute to vascular inflammation, remodeling and increased cardiovascular risk. Endothelial cells are therefore an important model for studying non-genomic aldosterone signaling.
Glucocorticoid-remediable aldosteronism
Glucocorticoid-remediable aldosteronism is caused by a chimeric gene resulting from unequal crossing over between CYP11B1 and CYP11B2, leading to ectopic aldosterone synthase expression under ACTH control. This results in excessive aldosterone production and altered cellular responses in target tissues, often presenting as early-onset hypertension.
From cellular response to aldosterone-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of NR3C2 abolish cellular response to aldosterone? | NR3C2 knockout in renal epithelial or vascular endothelial cells [1,3] |
| How do KCNJ5 mutations alter adrenal cell aldosterone production? | KCNJ5 point mutation knock-in in adrenal cell lines |
| Can a disease-associated CYP11B2 variant drive constitutive aldosterone synthesis? | CYP11B2 knock-in or overexpression in adrenal cells |
| What is the role of EGR1 in oxidative stress and aldosterone production? | EGR1 knockout and tagged knock-in for localization studies |
| How does HSD11B2 protect the mineralocorticoid receptor from cortisol? | HSD11B2 knockout in renal cells and measurement of MR activation |
| Which genes mediate rapid non-genomic aldosterone signaling? | CRISPR library screening in endothelial cells followed by RNA-seq |
How to Study the cellular response to aldosterone Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify aldosterone-regulated transcriptional programs [1,6] |
| Single-cell multiomics | Cellular heterogeneity and gene expression | Study aldosterone-producing adenoma ecosystems |
| CRISPR knockout | Loss-of-function effects on aldosterone response | Validate candidate genes such as NR3C2 |
| CRISPR knock-in | Effect of specific mutations | Model KCNJ5 or CYP11B2 variants [2,5] |
| Proteomics | Protein abundance and modifications | Quantify downstream signaling effectors |
| Live-cell imaging | Dynamic changes in calcium, pH, membrane potential | Measure rapid non-genomic aldosterone effects |
| Electrophysiology | Ion channel activity | Assess ENaC or KCNJ5 function [2,4] |
| Steroid profiling | Aldosterone and precursor levels | Evaluate aldosterone production in adrenal cells |
Transcriptomic profiling
RNA sequencing (RNA-seq) is widely used to measure changes in gene expression following aldosterone stimulation, revealing transcriptional programs controlled by the mineralocorticoid receptor [1,6]. In aldosterone-producing adenomas, single-cell RNA-seq and multiomics have uncovered distinct cellular ecosystems and mutation-specific expression signatures.
Functional genomics with CRISPR
CRISPR-Cas9 knockout, point mutation and knock-in models enable causal testing of candidate genes in cellular response to aldosterone. For example, knocking out NR3C2 or mutating KCNJ5 can reveal their roles in aldosterone signaling and production [2,3]. Library screening can identify novel regulators of aldosterone response in a high-throughput manner.
Protein and metabolite analysis
Proteomics and metabolomics can quantify downstream effects of aldosterone, such as changes in ion channel abundance, kinase activity and steroid metabolites [2,6]. These methods complement transcriptomics to provide a systems-level view of the cellular response.
Imaging and electrophysiology
Live-cell imaging and electrophysiology measure rapid non-genomic effects of aldosterone, including changes in intracellular calcium, membrane potential and ion channel activity [4,8]. These techniques are essential for dissecting the temporal dynamics of aldosterone signaling.
How CRISPR Can Be Used to Study GO:1904045 cellular response to aldosterone
Knockout
CRISPR knockout of genes such as NR3C2, SGK1 or SCNN1A can abolish or reduce cellular response to aldosterone, providing causal evidence for their roles [1,3]. Knockout models are also used to study loss-of-function mutations in aldosterone-producing adenomas, such as ATP1A1 or ATP2B3.
Point Mutation
Point mutation knock-in via CRISPR is ideal for modeling specific disease-associated variants, such as KCNJ5 G151R or L168R, which alter channel selectivity and drive aldosterone production. These models help dissect how single amino acid changes affect cellular response to aldosterone.
Knock-in
Knock-in of reporter tags or disease alleles, such as chimeric CYP11B1/CYP11B2, allows tracking of aldosterone synthase expression and function in adrenal cells. Tagged knock-in of NR3C2 can reveal receptor localization and dynamics.
Overexpression
Overexpression of aldosterone pathway genes, such as CYP11B2 or EGR1, can mimic hyperaldosteronism states and reveal downstream cellular changes [5,6]. Overexpression models are useful for testing whether a gene is sufficient to drive aldosterone-related phenotypes.
How EDITGENE Supports cellular response to aldosterone Research
Researchers studying cellular response to aldosterone-related genes often need to determine whether a candidate gene is causally involved in aldosterone sensing, signaling or production. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling functional validation of genes implicated in GO:1904045 and related pathways.
Contact EDITGENE today to design your custom CRISPR model for cellular response to aldosterone research.
Frequently Asked Questions About cellular response to aldosterone
What is GO:1904045 cellular response to aldosterone?
GO:1904045 is a Gene Ontology biological process term describing any change in a cell's state or activity in response to an aldosterone stimulus, including movement, secretion, enzyme production and gene expression.
What genes are involved in cellular response to aldosterone?
Key genes include NR3C2 (mineralocorticoid receptor), SGK1, SCNN1A/B/G (ENaC subunits), ATP1A1, KCNJ5, CYP11B2, EGR1 and HSD11B2 [1,2,3,5,6,7].
How does aldosterone affect cells?
Aldosterone binds the mineralocorticoid receptor, which translocates to the nucleus and regulates transcription of genes controlling ion transport, oxidative stress and inflammation; it also triggers rapid non-genomic signaling [1,3,4].
What diseases are linked to cellular response to aldosterone?
Primary aldosteronism, hypertension, cardiac fibrosis, heart failure and vascular endothelial dysfunction are linked to dysregulated aldosterone responses [1,3,4,8].
What is the role of KCNJ5 in aldosterone-producing adenomas?
Mutations in KCNJ5 alter potassium channel selectivity, leading to membrane depolarization, calcium influx and increased aldosterone production in adrenal cells.
How can CRISPR be used to study cellular response to aldosterone?
CRISPR knockout, point mutation and knock-in models can validate the causal role of genes such as NR3C2, KCNJ5 and CYP11B2 in aldosterone signaling and production [2,3,5].
What is the mineralocorticoid receptor?
NR3C2 is a ligand-activated transcription factor that binds aldosterone and mediates genomic and some non-genomic cellular responses to the hormone [1,3].
What is non-genomic aldosterone signaling?
Non-genomic signaling refers to rapid cellular effects of aldosterone that occur within minutes and do not require transcription, often involving kinases and ion channels [4,8].
How is aldosterone production regulated?
Aldosterone production is controlled by the renin-angiotensin-aldosterone system, ACTH in glucocorticoid-remediable aldosteronism, and somatic mutations in adrenal tumors [1,2,5].
What methods are used to study cellular response to aldosterone?
Common methods include RNA-seq, single-cell multiomics, CRISPR screens, proteomics, live-cell imaging and electrophysiology [1,2,4,6].
Conclusion
Cellular response to aldosterone (GO:1904045) is a fundamental biological process that connects hormonal signaling to ion transport, gene expression and cellular behavior. Its dysregulation is central to primary aldosteronism, hypertension, cardiac fibrosis and vascular disease, making it a high-priority area for mechanistic and translational research [1,3,4,8]. Advances in multiomics and CRISPR-based models are revealing new insights into aldosterone-producing adenomas and mutation-specific cellular ecosystems [2,6]. By leveraging precise gene editing tools, researchers can dissect the causal roles of genes such as NR3C2, KCNJ5 and CYP11B2 in aldosterone responses. EDITGENE supports this effort with comprehensive knockout, point mutation, knock-in, overexpression and library screening services tailored to aldosterone biology.
References
- 1. Te Riet L et al.. 2015. Hypertension: renin-angiotensin-aldosterone system alterations.. Circ Res 116(6):960-75 PMID: 25767283
- 2. Yokomoto-Umakoshi M et al.. 2025. Multiomics analysis unveils the cellular ecosystem with clinical relevance in aldosterone-producing adenomas with KCNJ5 mutations.. Proc Natl Acad Sci U S A 122(9):e2421489122 PMID: 40009643
- 3. Gordon RD. 1995. Primary aldosteronism.. J Endocrinol Invest 18(7):495-511 PMID: 9221268
- 4. Crompton M et al.. 2023. Aldosterone: Essential for Life but Damaging to the Vascular Endothelium.. Biomolecules 13(6) PMID: 37371584
- 5. Williams GH et al.. 1995. Glucocorticoid-remediable aldosteronism.. J Endocrinol Invest 18(7):512-7 PMID: 9221269
- 6. Pang Y et al.. 2025. EGR1 regulates oxidative stress and aldosterone production in adrenal cells and aldosterone-producing adenomas.. Redox Biol 80:103498 PMID: 39826326
- 7. Gasparini S et al.. 2024. Aldosterone-induced salt appetite requires HSD2 neurons.. JCI Insight 9(23) PMID: 39446486
- 8. Catena C et al.. 2012. Aldosterone and the heart: from basic research to clinical evidence.. Horm Metab Res 44(3):181-7 PMID: 22095099
